van Daele PLA - Search Results

1

Management around invasive procedures in mastocytosis: An update.

Hermans MAW, Arends NJT, Gerth van Wijk R, van Hagen PM, Kluin-Nelemans HC, Oude Elberink HNG, Pasmans SGMA, van Daele PLA. Hermans MAW, et al. Among authors: van hagen pm, van daele pla. Ann Allergy Asthma Immunol. 2017 Oct;119(4):304-309. doi: 10.1016/j.anai.2017.07.022. Epub 2017 Aug 31. Ann Allergy Asthma Immunol. 2017. PMID: 28866309 Review.

2

Successful treatment of CRPS 1 with anti-TNF.

Huygen FJ, Niehof S, Zijlstra FJ, van Hagen PM, van Daele PL. Huygen FJ, et al. J Pain Symptom Manage. 2004 Feb;27(2):101-3. doi: 10.1016/j.jpainsymman.2003.12.006. J Pain Symptom Manage. 2004. PMID: 15157033 Free article. No abstract available.

3

[Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication].

van Laar JA, Jamnitski A, Baarsma GS, van Daele PL, van Hagen PM. van Laar JA, et al. Ned Tijdschr Geneeskd. 2006 Apr 1;150(13):705-9. Ned Tijdschr Geneeskd. 2006. PMID: 16623340 Dutch.

4

Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.

Droogendijk HJ, Kluin-Nelemans HJ, van Doormaal JJ, Oranje AP, van de Loosdrecht AA, van Daele PL. Droogendijk HJ, et al. Cancer. 2006 Jul 15;107(2):345-51. doi: 10.1002/cncr.21996. Cancer. 2006. PMID: 16779792 Free article. Clinical Trial.

5

TB or not TB: treat to see.

van Daele PL, Bakker M, van Hagen PM, Baarsma GS, Kuijpers RW. van Daele PL, et al. Med J Aust. 2006 Aug 7;185(3):178-9. doi: 10.5694/j.1326-5377.2006.tb00515.x. Med J Aust. 2006. PMID: 16893366 No abstract available.

6

Octreotide long-acting repeatable for the treatment of chronic macular edema in uveitis.

Missotten T, van Laar JA, van der Loos TL, van Daele PL, Kuijpers RW, Baarsma GS, van Hagen PM. Missotten T, et al. Am J Ophthalmol. 2007 Dec;144(6):838-843. doi: 10.1016/j.ajo.2007.07.039. Epub 2007 Oct 4. Am J Ophthalmol. 2007. PMID: 17916316

7

Is imatinib mesylate a promising drug in systemic sclerosis?

van Daele PL, Dik WA, Thio HB, van Hal PT, van Laar JA, Hooijkaas H, van Hagen PM. van Daele PL, et al. Arthritis Rheum. 2008 Aug;58(8):2549-52. doi: 10.1002/art.23648. Arthritis Rheum. 2008. PMID: 18668570 Free article.

8

Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.

van Steensel L, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA. van Steensel L, et al. Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3091-8. doi: 10.1167/iovs.08-2443. Epub 2009 Feb 21. Invest Ophthalmol Vis Sci. 2009. PMID: 19234339

9

Do synovial biopsies help to support evidence for involvement of innate immunity in the immunopathology of Behçet's disease?

van Laar JA, Kappen JH, van Daele PL, van Hagen PM. van Laar JA, et al. Arthritis Res Ther. 2009;11(2):109. doi: 10.1186/ar2657. Epub 2009 Apr 30. Arthritis Res Ther. 2009. PMID: 19439057 Free PMC article.

10

Managing Behçet's disease: An update on current and emerging treatment options.

van Daele PL, Kappen JH, van Hagen PM, van Laar JA. van Daele PL, et al. Ther Clin Risk Manag. 2009 Apr;5(2):385-90. doi: 10.2147/tcrm.s4446. Epub 2009 May 20. Ther Clin Risk Manag. 2009. PMID: 19536320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page